NASHVILLE, Tenn., Oct. 23, 2024 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) plans to release its third quarter 2024 financial results after the market closes on Wednesday, November 6, 2024. The Company also plans to discuss the results on a conference call scheduled for Thursday, November 7, 2024, at 9:00 a.m. (ET).
BROOKDALE SENIOR LIVING - EARNINGS CALL
Date: Thursday, November 7, 2024
Time: 9:00 a.m. (ET) / 8:00 a.m. (CT)
brookdaleinvestors.com
Call Within US: +1 (800) 715-9871
Call Outside US: +1 (646) 307-1963
Conference ID: 1482282
A webcast of the conference call will be available to the public on a listen-only basis at brookdaleinvestors.com. Please allow extra time before the call to download the necessary software required to listen to the internet broadcast.
For those who cannot listen to the live call, a replay of the webcast will be available until 11:59 p.m. (ET) on November 14, 2024 by dialing +1 (800) 770-2030 (from within the U.S. & Canada) or all other locations +1 (647) 362-9199 and entering Playback ID: 1482282#.
About Brookdale Senior Living
Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care, connection, and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, make new friends, and stay connected with loved ones. Brookdale, through its affiliates, operates and manages 648 communities in 41 states as of September 30, 2024, with the ability to serve approximately 58,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.
Last Trade: | US$5.07 |
Daily Change: | -0.04 -0.78 |
Daily Volume: | 283,882 |
Market Cap: | US$1.010B |
December 09, 2024 November 11, 2024 November 06, 2024 September 30, 2024 September 10, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB